<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Physiology</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Physiology</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский физиологический журнал им. И.М. Сеченова</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0869-8139</issn><issn publication-format="electronic">2658-655X</issn><publisher><publisher-name xml:lang="en">The Russian Academy of Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">651665</article-id><article-id pub-id-type="doi">10.31857/S0869813924030086</article-id><article-id pub-id-type="edn">CPLWKK</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>EXPERIMENTAL ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ЭКСПЕРИМЕНТАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Activated Endothelium Changes The Activity Of Multipotent Mesenchymal Stromal Cells During Physiological Hypoxia Or Short Hypoxic Stress In Vitro</article-title><trans-title-group xml:lang="ru"><trans-title>Активированный эндотелий стимулирует активность мультипотентных мезенхимальных стромальных клеток при физиологической гипоксии и коротком гипоксическом стрессе in vitro</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zhidkova</surname><given-names>O. V.</given-names></name><name xml:lang="ru"><surname>Жидкова</surname><given-names>О. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>flain-fish@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Andreeva</surname><given-names>E. R.</given-names></name><name xml:lang="ru"><surname>Андреева</surname><given-names>Е. Р.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>andreeva1564@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Buravkova</surname><given-names>L. B.</given-names></name><name xml:lang="ru"><surname>Буравкова</surname><given-names>Л. Б.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>buravkova@imbp.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Institute of Biomedical Problems, Russian Academy of Sciences</institution></aff><aff><institution xml:lang="ru">Институт медико-биологических проблем РАН</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2024-03-15" publication-format="electronic"><day>15</day><month>03</month><year>2024</year></pub-date><volume>110</volume><issue>3</issue><issue-title xml:lang="ru"/><fpage>445</fpage><lpage>468</lpage><history><date date-type="received" iso-8601-date="2025-02-01"><day>01</day><month>02</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Russian Academy of Sciences</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, Российская академия наук</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Russian Academy of Sciences</copyright-holder><copyright-holder xml:lang="ru">Российская академия наук</copyright-holder></permissions><self-uri xlink:href="https://journals.eco-vector.com/0869-8139/article/view/651665">https://journals.eco-vector.com/0869-8139/article/view/651665</self-uri><abstract xml:lang="en"><p>Multipotent mesenchymal stromal cells (MSCs) are used for supplemental therapy of ischemic and inflammatory diseases. After systemic administration, transmigration of MSCs to the target tissue is accompanied by interaction with activated endothelial cells (ECs) at the site of injury. In this study, we investigated the influence of TNF-α-activated ECs on the functions of MSCs under different levels of hypoxia. For this purpose, MSCs and TNF-α activated ECs were cocultured in a direct cell-to-cell setting for a short period of time. MSCs retained their stromal phenotype and multilineage differentiation potential after interaction with activated ECs. At the same time, changes in molecules involved in MSC-cell and MSC-extracellular matrix interaction were detected. The paracrine activity of MSCs and activated ECs after interaction was demonstrated by both upregulated transcription and increased levels of pleiotropic IL-6 and IL-8. Proteases/antiproteases profiles were also altered after interaction. These data suggest that short-term interaction of MSCs with activated ECs may play an important role in tissue repair and remodeling processes. In particular, it may promote the migratory phenotype of MSCs. In comparison to physiological hypoxia – 5% O<sub>2</sub>, acute hypoxic stress (0.1% O<sub>2</sub>, 24 h) attenuated the stimulatory effects of ECs on MSCs.</p></abstract><trans-abstract xml:lang="ru"><p>Мультипотентные мезенхимальные стромальные клетки (МСК) применяются для дополнительной терапии ишемических и воспалительных заболеваний. При системном введении трансмиграция МСК в ткани-мишени сопровождается взаимодействием с активированными эндотелиальными клетками (ЭК), выстилающими сосуды в участках повреждений. В настоящей работе изучали эффекты активированных ФНО-α эндотелиальных клеток на активность МСК при гипоксии разной степени выраженности. Для этого использовали модель краткосрочного контактного сокультивирования МСК и предварительно активированных ФНО-α эндотелиальных клеток. После взаимодействия с<bold> </bold>активированными ЭК МСК сохраняли свой стромальный фенотип, потенциал к мультилинейной дифференцировке. В то же время выявлено изменение экспрессии молекул межклеточного взаимодействия, которые участвуют в формировании контактов МСК с другими клетками, матриксом, а также регулируют деградацию внеклеточного матрикса (ВКМ) и клеточную миграцию. Кроме того, кондиционированная среда от активированного эндотелия увеличивала направленную и ненаправленную миграцию МСК. Взаимодействие усиливало паракринный ответ МСК и активированных ЭК за счет увеличения транскрипции и продукции ИЛ-6, ИЛ-8. В совокупности эти данные указывают на то, что краткосрочное взаимодействие с активированными ЭК способствует формированию миграционного фенотипа МСК, а также увеличивает продукцию плейотропных цитокинов и протеаз/ингибиторов протеаз, которые регулируют процессы репарации и ремоделирования ткани. При этом по сравнению с физиологическими для МСК условиями (5% О<sub>2</sub>) острый гипоксический стресс (0.1% О<sub>2</sub>, 24 ч) ослаблял стимулирующее действие эндотелия на МСК.</p></trans-abstract><kwd-group xml:lang="en"><kwd>multipotent mesenchymal stromal cells</kwd><kwd>endothelial cells</kwd><kwd>hypoxia</kwd><kwd>proinflammatory activation</kwd><kwd>cocultivation</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>мультипотентные мезенхимальные стромальные клетки</kwd><kwd>эндотелиальные клетки</kwd><kwd>гипоксия</kwd><kwd>провоспалительная активация</kwd><kwd>сокультивирование</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution xml:lang="ru">Правительство РФ</institution></institution-wrap><institution-wrap><institution xml:lang="en">Government of the Russian Federation</institution></institution-wrap></funding-source><award-id>FMFR-2024-0032</award-id></award-group><award-group><funding-source><institution-wrap><institution xml:lang="ru">Правительство РФ</institution></institution-wrap><institution-wrap><institution xml:lang="en">Government of the Russian Federation</institution></institution-wrap></funding-source><award-id>65.3</award-id></award-group></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Caplan AI, Correa D (2011) The MSC: An Injury Drugstore. Cell Stem Cell 9: 11–15. https://doi.org/10.1016/j.stem.2011.06.008</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Squillaro T, Peluso G, Galderisi U (2016) Clinical Trials with Mesenchymal Stem Cells: An Update. Cell Transplant 25: 829–848. https://doi.org/10.3727/096368915X689622</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Galipeau J, Sensébé L (2018) Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities. Cell Stem Cell 22: 824–833. https://doi.org/10.1016/j.stem.2018.05.004</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Fernández-Garza LE, Barrera-Barrera SA, Barrera-Saldaña HA (2023) Mesenchymal Stem Cell Therapies Approved by Regulatory Agencies around the World. Pharmaceuticals 16: 1334. https://doi.org/10.3390/ph16091334</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Buravkova LB, Andreeva ER, Gogvadze V, Zhivotovsky B (2014) Mesenchymal stem cells and hypoxia: Where are we? Mitochondrion 19: 105–112. https://doi.org/10.1016/j.mito.2014.07.005</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Egger D, Lavrentieva A, Kugelmeier P, Kasper C (2022) Physiologic isolation and expansion of human mesenchymal stem/stromal cells for manufacturing of cell-based therapy products. Eng Life Sci 22: 361–372. https://doi.org/10.1002/elsc.202100097</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Choi J-W, Shin S, Lee CY, Lee J, Seo H-H, Lim S, Lee S, Kim I-K, Lee H-B, Kim SW, Hwang K-C (2017) Rapid Induction of Osteogenic Markers in Mesenchymal Stem Cells by Adipose-Derived Stromal Vascular Fraction Cells. Cell Physiol Biochem 44: 53–65. https://doi.org/10.1159/000484582</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Lavrentieva A, Majore I, Kasper C, Hass R (2010) Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells. Cell Commun Signal CCS 8: 18. https://doi.org/10.1186/1478-811X-8-18</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Moniz I, Ramalho-Santos J, Branco AF (2022) Differential Oxygen Exposure Modulates Mesenchymal Stem Cell Metabolism and Proliferation through mTOR Signaling. Int J Mol Sci 23: 3749. https://doi.org/10.3390/ijms23073749</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Rosová I, Dao M, Capoccia B, Link D, Nolta JA (2008) Hypoxic Preconditioning Results in Increased Motility and Improved Therapeutic Potential of Human Mesenchymal Stem Cells. Stem Cells 26: 2173–2182. https://doi.org/10.1634/stemcells.2007-1104</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Udartseva OO, Lobanova MV, Andreeva ER, Buravkov SV, Ogneva IV, Buravkova LB (2016) Acute Hypoxic Stress Affects Migration Machinery of Tissue O2-Adapted Adipose Stromal Cells. Stem Cells Int 2016: 1–16. https://doi.org/10.1155/2016/7260562</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Busletta C, Novo E, Valfrè Di Bonzo L, Povero D, Paternostro C, Ievolella M, Mareschi K, Ferrero I, Cannito S, Compagnone A, Bandino A, Colombatto S, Fagioli F, Parola M (2011) Dissection of the Biphasic Nature of Hypoxia-Induced Motogenic Action in Bone Marrow-Derived Human Mesenchymal Stem Cells. Stem Cells 29: 952–963. https://doi.org/10.1002/stem.642</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Wang Q, Li X, Wang Q, Xie J, Xie C, Fu X (2019) Heat shock pretreatment improves mesenchymal stem cell viability by heat shock proteins and autophagy to prevent cisplatin-induced granulosa cell apoptosis. Stem Cell Res Ther 10: 348. https://doi.org/10.1186/s13287-019-1425-4</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Peterson KM, Aly A, Lerman A, Lerman LO, Rodriguez-Porcel M (2011) Improved survival of mesenchymal stromal cell after hypoxia preconditioning: role of oxidative stress. Life Sci 88: 65–73. https://doi.org/10.1016/j.lfs.2010.10.023</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Andreeva ER, Lobanova MV, Udartseva OO, Buravkova LB (2014) Response of Adipose Tissue-Derived Stromal Cells in Tissue-Related O2 Microenvironment to Short-Term Hypoxic Stress. Cells Tissues Organs 200: 307–315. https://doi.org/10.1159/000438921</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Caplan AI (2007) Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213: 341–347. https://doi.org/10.1002/jcp.21200</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Wei X, Yang X, Han Z, Qu F, Shao L, Shi Y (2013) Mesenchymal stem cells: a new trend for cell therapy. Acta Pharmacol Sin 34: 747–754. https://doi.org/10.1038/aps.2013.50</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Lu L, Xu A, Gao F, Tian C, Wang H, Zhang J, Xie Y, Liu P, Liu S, Yang C, Ye Z, Wu X (2022) Mesenchymal Stem Cell-Derived Exosomes as a Novel Strategy for the Treatment of Intervertebral Disc Degeneration. Front Cell Dev Biol 9: 770510. https://doi.org/10.3389/fcell.2021.770510</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Sanchez-Diaz M, Quiñones-Vico MI, Sanabria De La Torre R, Montero-Vílchez T, Sierra-Sánchez A, Molina-Leyva A, Arias-Santiago S (2021) Biodistribution of Mesenchymal Stromal Cells after Administration in Animal Models and Humans: A Systematic Review. J Clin Med 10: 2925. https://doi.org/10.3390/jcm10132925</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Becker AD, Riet IV (2016) Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy? World J Stem Cells 8: 73. https://doi.org/10.4252/wjsc.v8.i3.73</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Szydlak R (2021) Biological, chemical and mechanical factors regulating migration and homing of mesenchymal stem cells. World J Stem Cells 13: 619–631. https://doi.org/10.4252/wjsc.v13.i6.619</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Leibacher J, Dauber K, Ehser S, Brixner V, Kollar K, Vogel A, Spohn G, Schäfer R, Seifried E, Henschler R (2017) Human mesenchymal stromal cells undergo apoptosis and fragmentation after intravenous application in immune-competent mice. Cytotherapy 19: 61–74. https://doi.org/10.1016/j.jcyt.2016.09.010</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Zachar L, Bačenková D, Rosocha J (2016) Activation, homing, and role of the mesenchymal stem cells in the inflammatory environment. J Inflamm Res 9: 231–240. https://doi.org/10.2147/JIR.S121994</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Nitzsche F, Müller C, Lukomska B, Jolkkonen J, Deten A, Boltze J (2017) Concise Review: MSC Adhesion Cascade—Insights into Homing and Transendothelial Migration. Stem Cells 35: 1446–1460. https://doi.org/10.1002/stem.2614</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Teo GSL, Ankrum JA, Martinelli R, Boetto SE, Simms K, Sciuto TE, Dvorak AM, Karp JM, Carman CV (2012) Mesenchymal Stem Cells Transmigrate Between and Directly Through Tumor Necrosis Factor-α-Activated Endothelial Cells Via Both Leukocyte-Like and Novel Mechanisms. Stem Cells 30: 2472–2486. https://doi.org/10.1002/stem.1198</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Guo Y-C, Chiu Y-H, Chen C-P, Wang H-S (2018) Interleukin-1β induces CXCR3-mediated chemotaxis to promote umbilical cord mesenchymal stem cell transendothelial migration. Stem Cell Res Ther 9: 281. https://doi.org/10.1186/s13287-018-1032-9</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Merfeld-Clauss S, Lupov IP, Lu H, Feng D, Compton-Craig P, March KL, Traktuev DO (2014) Adipose Stromal Cells Differentiate Along a Smooth Muscle Lineage Pathway Upon Endothelial Cell Contact via Induction of Activin A. Circ Res 115: 800–809. https://doi.org/10.1161/CIRCRESAHA.115.304026</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Lin C-H, Lilly B (2014) Endothelial Cells Direct Mesenchymal Stem Cells Toward a Smooth Muscle Cell Fate. Stem Cells Dev 23: 2581–2590. https://doi.org/10.1089/scd.2014.0163</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Li C, Wu X, Tong J, Yang X, Zhao J, Zheng Q, Zhao G, Ma Z (2015) Comparative analysis of human mesenchymal stem cells from bone marrow and adipose tissue under xeno-free conditions for cell therapy. Stem Cell Res Ther 6: 55. https://doi.org/10.1186/s13287-015-0066-5</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Buravkova LB, Grinakovskaya OS, Andreeva ER, Zhambalova AP, Kozionova MP (2009) Characteristics of human lipoaspirate-isolated mesenchymal stromal cells cultivated under lower oxygen tension. Cell Tissue Biol 3: 23–28. https://doi.org/10.1134/S1990519X09010039</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini FC, Krause DS, Deans RJ, Keating A, Prockop DJ, Horwitz EM (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315–317. https://doi.org/10.1080/14653240600855905</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Tondreau T, Meuleman N, Stamatopoulos B, De Bruyn C, Delforge A, Dejeneffe M, Martiat P, Bron D, Lagneaux L (2009) In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues. Cytotherapy 11: 559–569. https://doi.org/10.1080/14653240903051541</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Lozito TP, Jackson WM, Nesti LJ, Tuan RS (2014) Human mesenchymal stem cells generate a distinct pericellular zone of MMP activities via binding of MMPs and secretion of high levels of TIMPs. Matrix Biol 34: 132–143. https://doi.org/10.1016/j.matbio.2013.10.003</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Beloglazova IB, Zubkova ES, Tsokolaeva ZI, Stafeev YuS, Dergilev KV, Ratner EI, Shestakova MV, Sukhareva OYu, Parfenova EV, Menshikov MYu (2016) Regulatory Effects of Urokinase on Mesenchymal Stromal Cell Migration, Proliferation, and Matrix Metalloproteinase Secretion. Bull Exp Biol Med 161: 775–778. https://doi.org/10.1007/s10517-016-3507-y</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Wei L, Xu Y, Zhang L, Yang L, Zhao RC, Zhao D (2023) Mesenchymal Stem Cells Promote Wound Healing and Effects on Expression of Matrix Metalloproteinases-8 and 9 in the Wound Tissue of Diabetic Rats. Stem Cells Dev 32: 25–31. https://doi.org/10.1089/scd.2021.0218</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Lee JA, Kim BI, Jo CH, Choi CW, Kim E-K, Kim H-S, Yoon K-S, Choi J-H (2010) Mesenchymal stem-cell transplantation for hypoxic-ischemic brain injury in neonatal rat model. Pediatr Res 67: 42–46. https://doi.org/10.1203/PDR.0b013e3181bf594b</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Pogodina MV, Buravkova LB (2014) Expression of hypoxia-associated genes in multipotent mesenchymal stromal cells during long-term cultivation at low oxygen. Dokl Biol Sci 458: 310–312. https://doi.org/10.1134/S0012496614050056</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Pulido-Escribano V, Torrecillas-Baena B, Camacho-Cardenosa M, Dorado G, Gálvez-Moreno MÁ, Casado-Díaz A (2022) Role of hypoxia preconditioning in therapeutic potential of mesenchymal stem-cell-derived extracellular vesicles. World J Stem Cells 14: 453–472. https://doi.org/10.4252/wjsc.v14.i7.453</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Fontani F, Domazetovic V, Marcucci T, Vincenzini MT, Iantomasi T (2016) Tumor Necrosis Factor-Alpha Up-Regulates ICAM-1 Expression and Release in Intestinal Myofibroblasts by Redox-Dependent and -Independent Mechanisms: ICAM-1 Expression and Release in 18C o Cells. J Cell Biochem 117: 370–381. https://doi.org/10.1002/jcb.25279</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Li M, Van Esch BCAM, Wagenaar GTM, Garssen J, Folkerts G, Henricks PAJ (2018) Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells. Eur J Pharmacol 831: 52–59. https://doi.org/10.1016/j.ejphar.2018.05.003</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Sigfrid LA, Cunningham JM, Beeharry N, Lortz S, Tiedge M, Lenzen S, Carlsson C, Green IC (2003) Cytokines and nitric oxide inhibit the enzyme activity of catalase but not its protein or mRNA expression in insulin-producing cells. J Mol Endocrinol 31: 509–518. https://doi.org/10.1677/jme.0.0310509</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Bauer G (2015) Increasing the endogenous NO level causes catalase inactivation and reactivation of intercellular apoptosis signaling specifically in tumor cells. Redox Biol 6: 353–371. https://doi.org/10.1016/j.redox.2015.07.017</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Mussbacher M, Salzmann M, Brostjan C, Hoesel B, Schoergenhofer C, Datler H, Hohensinner P, Basílio J, Petzelbauer P, Assinger A, Schmid JA (2019) Cell Type-Specific Roles of NF-κB Linking Inflammation and Thrombosis. Front Immunol 10: 85. https://doi.org/10.3389/fimmu.2019.00085</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Frith JE, Mills RJ, Hudson JE, Cooper-White JJ (2012) Tailored Integrin–Extracellular Matrix Interactions to Direct Human Mesenchymal Stem Cell Differentiation. Stem Cells Dev 21: 2442–2456. https://doi.org/10.1089/scd.2011.0615</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Steward AJ, Kelly DJ (2015) Mechanical regulation of mesenchymal stem cell differentiation. J Anat 227: 717–731. https://doi.org/10.1111/joa.12243</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Huttenlocher A, Horwitz AR (2011) Integrins in Cell Migration. Cold Spring Harb Perspect Biol 3: a005074–a005074. https://doi.org/10.1101/cshperspect.a005074</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Becerra-Bayona SM, Guiza-Arguello VR, Russell B, Höök M, Hahn MS (2018) Influence of collagen-based integrin α1 and α2 mediated signaling on human mesenchymal stem cell osteogenesis in three dimensional contexts. J Biomed Mater Res A 106: 2594–2604. https://doi.org/10.1002/jbm.a.36451</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Winning S, Splettstoesser F, Fandrey J, Frede S (2010) Acute Hypoxia Induces HIF-Independent Monocyte Adhesion to Endothelial Cells through Increased Intercellular Adhesion Molecule-1 Expression: The Role of Hypoxic Inhibition of Prolyl Hydroxylase Activity for the Induction of NF-κB. J Immunol 185: 1786–1793. https://doi.org/10.4049/jimmunol.0903244</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Thin Luu N, Mcgettrick HM, Buckley CD, Newsome PN, Ed Rainger G, Frampton J, Nash GB (2013) Crosstalk Between Mesenchymal Stem Cells and Endothelial Cells Leads to Downregulation of Cytokine-Induced Leukocyte Recruitment. Stem Cells 31: 2690–2702. https://doi.org/10.1002/stem.1511</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Bartaula-Brevik S (2017) Secretome of Mesenchymal Stem Cells Grown in Hypoxia Accelerates Wound Healing and Vessel Formation In Vitro. Int J Stem Cell Res Ther 4. https://doi.org/10.23937/2469-570X/1410045</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Hao Q, Wang L, Tang H (2009) Vascular endothelial growth factor induces protein kinase D-dependent production of proinflammatory cytokines in endothelial cells. Am J Physiol-Cell Physiol 296: C821–C827. https://doi.org/10.1152/ajpcell.00504.2008</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Guillamat-Prats R (2022) Role of Mesenchymal Stem/Stromal Cells in Coagulation. Int J Mol Sci 23: 10393. https://doi.org/10.3390/ijms231810393</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Lund LR, Green KA, Stoop AA, Ploug M, Almholt K, Lilla J, Nielsen BS, Christensen IJ, Craik CS, Werb Z, Danø K, Rømer J (2006) Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice. EMBO J 25: 2686–2697. https://doi.org/10.1038/sj.emboj.7601173</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Rundhaug JE (2005) Matrix metalloproteinases and angiogenesis. J Cell Mol Med 9: 267–285. https://doi.org/10.1111/j.1582-4934.2005.tb00355.x</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>McCarty SM, Percival SL (2013) Proteases and Delayed Wound Healing. Adv Wound Care 2: 438–447. https://doi.org/10.1089/wound.2012.0370</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Shalini S, Dorstyn L, Dawar S, Kumar S (2015) Old, new and emerging functions of caspases. Cell Death Differ 22: 526–539. https://doi.org/10.1038/cdd.2014.216</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Habič A, Novak M, Majc B, Lah Turnšek T, Breznik B (2021) Proteases Regulate Cancer Stem Cell Properties and Remodel Their Microenvironment. J Histochem Cytochem 69: 775–794. https://doi.org/10.1369/00221554211035192</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Brauer PR (2006) MMPs-Role in Cardiovascular Development and Disease. Front Biosci 11: 447. https://doi.org/10.2741/1810</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>Kasper G, Glaeser JD, Geissler S, Ode A, Tuischer J, Matziolis G, Perka C, Duda GN (2007) Matrix Metalloprotease Activity Is an Essential Link Between Mechanical Stimulus and Mesenchymal Stem Cell Behavior. Stem Cells 25: 1985–1994. https://doi.org/10.1634/stemcells.2006-0676</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>De Becker A, Van Hummelen P, Bakkus M, Vande Broek I, De Wever J, De Waele M, Van Riet I (2007) Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3. Haematologica 92: 440–449. https://doi.org/10.3324/haematol.10475</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>Ries C, Egea V, Karow M, Kolb H, Jochum M, Neth P (2007) MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Blood 109: 4055–4063. https://doi.org/10.1182/blood-2006-10-051060</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>Tong B, Wan B, Wei Z, Wang T, Zhao P, Dou Y, Lv Z, Xia Y, Dai Y (2014) Role of cathepsin B in regulating migration and invasion of fibroblast-like synoviocytes into inflamed tissue from patients with rheumatoid arthritis. Clin Exp Immunol 177: 586–597. https://doi.org/10.1111/cei.12357</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation>Vangala G, Imhoff FM, Squires CML, Cridge AG, Baird SK (2019) Mesenchymal stem cell homing towards cancer cells is increased by enzyme activity of cathepsin D. Exp Cell Res 383: 111494. https://doi.org/10.1016/j.yexcr.2019.07.007</mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation>Vidak E, Javoršek U, Vizovišek M, Turk B (2019) Cysteine Cathepsins and their Extracellular Roles: Shaping the Microenvironment. Cells 8: 264. https://doi.org/10.3390/cells8030264</mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation>Park S, Huang H, Kwon W, Kim H, Park J, Han JE, Cho G, Han S, Sung Y, Ryoo ZY, Kim MO, Choi S (2021) Cathepsin A regulates pluripotency, proliferation and differentiation in mouse embryonic stem cells. Cell Biochem Funct 39: 67–76. https://doi.org/10.1002/cbf.3554</mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation>Mott JD, Werb Z (2004) Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 16: 558–564. https://doi.org/10.1016/j.ceb.2004.07.010</mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation>Stefansson S, Lawrence DA (1996) The serpin PAI-1 inhibits cell migration by blocking integrin αvβ3 binding to vitronectin. Nature 383: 441–443. https://doi.org/10.1038/383441a0</mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation>Richard B, Pichon S, Arocas V, Venisse L, Berrou E, Bryckaert M, Jandrot Perrus M, Bouton MC (2006) The serpin protease nexin-1 regulates vascular smooth muscle cell adhesion, spreading, migration and response to thrombin. J Thromb Haemost 4: 322–328. https://doi.org/10.1111/j.1538-7836.2006.01710.x</mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation>Provençal M, Michaud M, Beaulieu É, Ratel D, Rivard G-É, Gingras D, Béliveau R (2008) Tissue factor pathway inhibitor (TFPI) interferes with endothelial cell migration by inhibition of both the Erk pathway and focal adhesion proteins. Thromb Haemost 99: 576–585. https://doi.org/10.1160/TH07-10-0623</mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation>Saller MM, Prall WC, Docheva D, Schönitzer V, Popov T, Anz D, Clausen-Schaumann H, Mutschler W, Volkmer E, Schieker M, Polzer H (2012) Increased stemness and migration of human mesenchymal stem cells in hypoxia is associated with altered integrin expression. Biochem Biophys Res Commun 423: 379–385. https://doi.org/10.1016/j.bbrc.2012.05.134</mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation>Choi JH, Lee YB, Jung J, Hwang SG, Oh I-H, Kim GJ (2016) Hypoxia Inducible Factor-1 α Regulates the Migration of Bone Marrow Mesenchymal Stem Cells via Integrin α4. Stem Cells Int 2016: 1–11. https://doi.org/10.1155/2016/7932185</mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation>Ren G, Roberts AI, Shi Y (2011) Adhesion molecules: Key players in mesenchymal stem cell-mediated immunosuppression. Cell Adhes Migr 5: 20–22. https://doi.org/10.4161/cam.5.1.13491</mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation>Mai J, Virtue A, Shen J, Wang H, Yang X-F (2013) An evolving new paradigm: endothelial cells – conditional innate immune cells. J Hematol Oncol 6: 61. https://doi.org/10.1186/1756-8722-6-61</mixed-citation></ref></ref-list></back></article>
